Scheduling BCG and IL-2 Injections for Bladder Cancer Immunotherapy Treatment
Reads0
Chats0
TLDR
In this paper , the authors proposed the most extensive ordinary differential equation-based biological model of BCG treatment to date and a deep learning-based scheduling approach to obtain a personalized treatment schedule.Abstract:
Cancer is one of the most common families of diseases today with millions of new patients every year around the world. Bladder cancer (BC) is one of the most prevalent types of cancer affecting both genders, and it is not known to be associated with a specific group in the population. The current treatment standard for BC follows a standard weekly Bacillus Calmette–Guérin (BCG) immunotherapy-based therapy protocol which includes BCG and IL-2 injections. Unfortunately, due to the biological and clinical complexity of the interactions between the immune system, treatment, and cancer cells, clinical outcomes vary significantly among patients. Unfortunately, existing models are commonly developed for a non-existing average patient or pose strict, unrealistic, expectations on the treatment process. In this work, we propose the most extensive ordinary differential equation-based biological model of BCG treatment to date and a deep learning-based scheduling approach to obtain a personalized treatment schedule. Our results show that resulting treatment schedules favorably compare with the current standard practices and the current state-of-the-art scheduling approach.read more
Citations
More filters
Journal ArticleDOI
Optimizing SMS Reminder Campaigns for Pre- and Post-Diagnosis Cancer Check-Ups using Socio-Demographics: An In-Silco Investigation Into Bladder Cancer
TL;DR: In this paper , the authors proposed a novel framework, accompanied by a high-resolution computer simulation, to investigate and optimize socio-demographic-based SMS reminder campaigns for cancer check-ups.
References
More filters
Journal ArticleDOI
Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020.
TL;DR: China is undergoing cancer transition with an increasing burden of lung cancer, gastrointestinal cancer, and breast cancers, and the burden of breast cancer is increasing globally.
Proceedings Article
Natural Actor-Critic
TL;DR: This paper investigates a novel model-free reinforcement learning architecture, the Natural Actor-Critic, where the actor updates are based on stochastic policy gradients employing Amari's natural gradient approach, while the critic obtains both the natural policy gradient and additional parameters of a value function simultaneously by linear regression.
Journal ArticleDOI
Natural Actor-Critic
Jan Peters,Stefan Schaal +1 more
TL;DR: It is shown that several well-known reinforcement learning methods such as the original Actor-Critic and Bradtke's Linear Quadratic Q-Learning are in fact Natural Actor- Critic algorithms.
Journal ArticleDOI
Big data and machine learning algorithms for health-care delivery
TL;DR: The benefits and challenges of big data and machine learning in health care are discussed, which include flexibility and scalability compared with traditional biostatistical methods, which makes it deployable for many tasks, such as risk stratification, diagnosis and classification, and survival predictions.
Proceedings ArticleDOI
Auto-Keras: An Efficient Neural Architecture Search System
Haifeng Jin,Qingquan Song,Xia Hu +2 more
TL;DR: In this article, the authors propose a novel framework enabling Bayesian optimization to guide the network morphism for efficient neural architecture search, which keeps the functionality of a neural network while changing its neural architecture, enabling more efficient training during the search.
Related Papers (5)
Natural and induced regulatory T cells: targets for immunotherapy of autoimmune disease and allergy.
Immunity, Cancer and Aging: Lessons from Mouse Models
Development of Personalized Combination Cancer Immunotherapy Based on the Patients’ Immune Status
Yutaka Kawakami,Li Qian,Naoshi Kawamura,Junichiro Miyazaki,Haruna Nagumo,Kinya Tsubota,Tomonari Kinoshita,Kenta Nakamua,Gaku Ohmura,Ryosuke Satomi,Juri Sugiyama,Hiroshi Nishio,Taeko Hayakawa,Boryana Popivanova,Sunthamala Nuchsupha,Tracy Hsin-ju Liu,Hajime Kamijuku,Chie Kudo-Saito,Nobuo Tsukamoto,Toshiharu Sakurai,Tomonobu Fujita,Tomonori Yaguchi +21 more